comparemela.com

Latest Breaking News On - Lisam caperelli - Page 5 : comparemela.com

Arbutus to Participate in Two Upcoming Investor Conferences

Arbutus to Participate in Two Upcoming Investor Conferences
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Lisam caperelliArbutus biopharma corporation nasdaqBiopharma corporationAnnual global investment conferenceFormal presentationHealthcare conferenceFireside chat

Arbutus Biopharma Corporation: Arbutus Reports Second Quarter 2023 Financial Results and Corporate Update

Arbutus Biopharma Corporation: Arbutus Reports Second Quarter 2023 Financial Results and Corporate Update
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesNew zealandN acetylgalactosamine galnacKaren simsMelissav rewolinskiElizabeth howardLisam caperelliWilliam collierDevice safety authority medsafeWorld health organizationInstitute for health metricsSecurities exchangeArbutus biopharma corporation nasdaqDrug administrationClinical developmentRoivant sciences ltd

Arbutus Reports Second Quarter 2023 Financial Results and Corporate Update

03.08.2023 - Regulatory approval received in New Zealand to advance AB-101, our oral PD-L1 inhibitor, into a Phase 1 clinical trial with dosing to begin this quarter AB-729 (imdusiran), in combination with pegylated interferon alfa-2a, in a Phase .

United statesNew zealandLisam caperelliMelissav rewolinskiN acetylgalactosamine galnacWilliam collierElizabeth howardKaren simsWorld health organizationDrug administrationSecurities exchangeArbutus biopharma corporation nasdaqClinical developmentRoivant sciences ltdDevice safety authority medsafeInstitute for health metrics

Arbutus to Report Second Quarter 2023 Financial Results and Provide Corporate Update

WARMINSTER, Pa., July 20, 2023 Arbutus Biopharma Corporation , a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target.

Lisam caperelliArbutus biopharma corporation nasdaqBiopharma corporation

Arbutus Appoints Melissa V Rewolinski, PhD to its Board of Directors

WARMINSTER, Pa., July 12, 2023 Arbutus Biopharma Corporation , a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target.

United statesWilliam collierLisam caperelliMelissav rewolinskiChemical development group leaderRice universitySecurities exchangeDevelopment for amira pharmaceuticalsLannett company incArbutus biopharma corporation nasdaqBiopharma corporationArbutus boardChief executive officerSenior vice presidentTechnical operationsSenior director

vimarsana © 2020. All Rights Reserved.